156 related articles for article (PubMed ID: 20177658)
1. Diabetes therapy and cancer risk: causal effects and other plausible explanations.
Hernández-Díaz S; Adami HO
Diabetologia; 2010 May; 53(5):802-8. PubMed ID: 20177658
[TBL] [Abstract][Full Text] [Related]
2. Insulin analogues and cancer risk: the emergence of second-generation studies.
Renehan AG
Diabetologia; 2012 Jan; 55(1):7-9. PubMed ID: 22033621
[TBL] [Abstract][Full Text] [Related]
3. Use of insulin glargine and cancer incidence in Scotland: a study from the Scottish Diabetes Research Network Epidemiology Group.
Colhoun HM;
Diabetologia; 2009 Sep; 52(9):1755-65. PubMed ID: 19603149
[TBL] [Abstract][Full Text] [Related]
4. Risk of cancer in patients receiving insulin glargine.
Dawson LK; Hamilton LA
Am J Health Syst Pharm; 2010 Dec; 67(23):2025-31. PubMed ID: 21098374
[TBL] [Abstract][Full Text] [Related]
5. New insulins and the risk of cancer.
Danne T; Bolinder J
Int J Clin Pract Suppl; 2010 Feb; (166):26-8. PubMed ID: 20377661
[TBL] [Abstract][Full Text] [Related]
6. Liraglutide vs insulin glargine and placebo in combination with metformin and sulfonylurea therapy in type 2 diabetes mellitus (LEAD-5 met+SU): a randomised controlled trial.
Russell-Jones D; Vaag A; Schmitz O; Sethi BK; Lalic N; Antic S; Zdravkovic M; Ravn GM; Simó R;
Diabetologia; 2009 Oct; 52(10):2046-55. PubMed ID: 19688338
[TBL] [Abstract][Full Text] [Related]
7. Cancer risk in diabetic patients treated with insulin glargine?
Prescrire Int; 2010 Aug; 19(108):162-3. PubMed ID: 20939447
[TBL] [Abstract][Full Text] [Related]
8. Insulin glargine controversy: a tribute to the editorial team at Diabetologia.
Butler PC
Diabetes; 2009 Nov; 58(11):2427-8. PubMed ID: 19875618
[No Abstract] [Full Text] [Related]
9. Risk of malignancies in patients with diabetes treated with human insulin or insulin analogues: a cohort study.
Hemkens LG; Grouven U; Bender R; Günster C; Gutschmidt S; Selke GW; Sawicki PT
Diabetologia; 2009 Sep; 52(9):1732-44. PubMed ID: 19565214
[TBL] [Abstract][Full Text] [Related]
10. Increased cancer-related mortality for patients with type 2 diabetes who use sulfonylureas or insulin.
Bowker SL; Majumdar SR; Veugelers P; Johnson JA
Diabetes Care; 2006 Feb; 29(2):254-8. PubMed ID: 16443869
[TBL] [Abstract][Full Text] [Related]
11. No evidence of increased risk of malignancies in patients with diabetes treated with insulin detemir: a meta-analysis.
Dejgaard A; Lynggaard H; Råstam J; Krogsgaard Thomsen M
Diabetologia; 2009 Dec; 52(12):2507-12. PubMed ID: 19838665
[TBL] [Abstract][Full Text] [Related]
12. Diabetes mellitus and increased risk of cancer: focus on metformin and the insulin analogs.
McFarland MS; Cripps R
Pharmacotherapy; 2010 Nov; 30(11):1159-78. PubMed ID: 20973689
[TBL] [Abstract][Full Text] [Related]
13. Diabetes, cancer and treatment - a mini-review.
Vestergaard P; Starup-Linde J
Curr Drug Saf; 2013 Nov; 8(5):292-5. PubMed ID: 24215309
[TBL] [Abstract][Full Text] [Related]
14. Diabetes and cancer: 5 years into the recent controversy.
Badrick E; Renehan AG
Eur J Cancer; 2014 Aug; 50(12):2119-25. PubMed ID: 24930060
[TBL] [Abstract][Full Text] [Related]
15. Incidence of malignancies in patients with diabetes mellitus and correlation with treatment modalities in a large Israeli health maintenance organization: a historical cohort study.
Buchs AE; Silverman BG
Metabolism; 2011 Oct; 60(10):1379-85. PubMed ID: 21696791
[TBL] [Abstract][Full Text] [Related]
16. [Insulin and cancer: myth or reality?].
Tran C; Gariani K; Philippe J
Rev Med Suisse; 2010 Jun; 6(252):1188-90, 1192. PubMed ID: 20614753
[TBL] [Abstract][Full Text] [Related]
17. Comparative safety of diabetes medications and risk of incident invasive breast cancer: a population-based cohort study.
Calip GS; Yu O; Elmore JG; Boudreau DM
Cancer Causes Control; 2016 May; 27(5):709-20. PubMed ID: 27053250
[TBL] [Abstract][Full Text] [Related]
18. [Insulin glargine and cancer: a storm in a glass of water?].
Scheen AJ; Lefebvre PJ
Rev Med Liege; 2009 Sep; 64(9):440-5. PubMed ID: 19947313
[TBL] [Abstract][Full Text] [Related]
19. Insulin glargine and incidence of cancer--an ongoing debate.
Hermanns N; Kulzer B
J Diabetes Sci Technol; 2010 Mar; 4(2):497-8. PubMed ID: 20307414
[No Abstract] [Full Text] [Related]
20. Diabetes treatment with insulin glargine and risk of malignancy: methodological pitfalls and ethical issues.
Simon D
Diabetologia; 2010 Jan; 53(1):204-5. PubMed ID: 19859691
[No Abstract] [Full Text] [Related]
[Next] [New Search]
